Group Says US Gov't Must Address Drug 'Patent Thickets'
A nonprofit group with a history of examining the U.S. drug patent system released a new blueprint on Tuesday aimed at addressing the use of patent thickets by pharmaceutical companies that allegedly...To view the full article, register now.
Already a subscriber? Click here to view full article